Although the present investigations are limited due to their retrospective study design and the mixture of various histologic subtypes of STS, our data indicates that Hb levels, which are frequently measured in the routinely tested complete blood count panel, may represent a potentially important variable that can be included with other clinico-pathological parameters and laboratory findings to create new cancer prognosis assessment models. The gene discussed is GSTM1; the disease is telomere syndrome.